| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 202.82 | 0.7% |
| Total Income | 203.41 | 0.5% |
| Expenditure | 185.70 | 0.9% |
| PBT | 3.63 | 76.1% |
| Net Profit | 2.41 | 75.9% |
| OPM | 10.99% | 14.18pp |
| NPM | 1.18% | 3.72pp |
| EPS | 0.91 | 76.0% |
Neogen Chemicals Delivers Robust Performance in FY25 Despite Adversities: Revenue at Rs. 778 crore, EBITDA at Rs. 136 crore
18 May 2025 · 18 May 2025, 06:01 pm
Summary
Neogen Chemicals Limited reported a strong financial performance for the year ended 31st March, 2025. In FY25, Neogen’s revenues stood at Rs. 778 crore, higher by 13% Y-o-Y. EBITDA for FY25 for Neogen stood at Rs. 136 crore, higher by 24% Y-o-Y. Neogen’s profit after tax for FY25 stood at Rs. 35 crore.
Key Highlights
- 1
Revenue at Rs. 778 crore, up 13% Y-o-Y
- 2
EBITDA at Rs. 136 crore, up 24% Y-o-Y
- 3
Neogen lonics’ FY25 revenue stood at Rs. 12 crore
- 4
EBITDA Margin for FY25 stood at 17.5%
- 5
Profit after tax for FY25 stood at Rs. 35 crore
- 6
Neogen is constructing a new plant at an adjacent location at the same site
Management Comments
Mr. Haridas Kanani
Chairman & Managing Director, Neogen Chemicals
We have closed FY25 on a strong note, achieving 13% revenue growth & 24% improvement in EBITDA. We accomplished this against a difficult & challenging global industry backdrop... Neogen Chemicals is well poised to leverage its expertise across multiple chemistries to drive sustained growth going forward.
Informational and educational content only. Not investment advice.